Stefania Mitola

Principal Investigator

Stefania Mitola has wide experience in research of endothelial cell and tumor cell biology as well as in the development of innovative approaches to target pathogenetic alterations of angiogenesis in human diseases.  She is particularly expert in the biochemical and molecular characterization of the interaction between soluble molecules and cell surface receptors that drive physio-pathological angiogenesis and tumor progression. Recently she has addressed the role of angiogenesis in metabolic diseases and in the regeneration of brown adipose tissue. During her career, she has received funding from AIRC foundation and the European Community’s Horizon 2020 Programme. Currently, she is funded by a AIRC Foundation Investigator Grant to study how targeting “inactivating” hotspot mutations of the kinase domain of tyrosine kinase receptors could help to fight tumor progression. Stefania Mitola has co-authored more than 100 scientific peer-reviewed articles. She has established research collaborations with numerous academic and non-academic partners (University of Milan, University of Naples, University of Campania, Italy; University of Thessaly, Greece; Yale School of Medicine, USA; Paul Scherrer Institute, Switzerland; Histocell, Spain; Discovery Foundation, Greece) who significantly contributed to her research achievements.

Academic activities

  • Full Professor in Biochemistry, University of Brescia, Brescia, Italy
  • Responsible of the Mechanobiology Research Center, University of Brescia, Brescia, Italy
  • Responsible of the Experimental Laboratory for the Preventive and Personalized Medicine, University of Brescia, Brescia, Italy
  • Director of the Master Degree in Medical Biotechnology, University of Brescia, Brescia, Italy
  • Member of the Board of Doctorate in Precision Medicine, University of Brescia, Brescia, Italy
  • Student laboratory training for experimental theses, usually 2 students per year